Literature DB >> 180917

Identification of the jaundiced infant who is likely to recover without surgical intervention.

D P Campbell, R Williams.   

Abstract

A series of 32 infants with persistant jaundice in whom an unequivocal differentiation between intrahepatic cholestasis and biliary atresia could not be made is reviewed. A protocol including Lipoprotein-X (LP-X) determinations before and after a short course of cholestyramine (CSM) was carried out in all. A fall in serum LP-X after CSM indicates the presence of patent extrahepatic bile ducts (even microscopic) which will function without benefit of hepatic portoenterostomy. A rise in LP-X levels after CSM means an atretic biliary system. The LP-X, CSM protocol was not able to differentiate between the anatomical variants of biliary atresia that may respond to hepatic portoenterostomy and those that will not. Patent bile ducts (even microscopic) in the porta hepatis and/or proximal hepatoduodenal ligament, which are in continuity with intrahepatic ducts, must be present if hepatic portoenterostomy is to be successful. None of our 12 infants undergoing hepatic portoenterostomy showed evidence of bile excretion after the procedure. Microscopic study of serial sections taken through the excised hepatoduodenal ligament tissues of these 12 infants revealed that none had anatomical findings conducive to the success of the operation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180917      PMCID: PMC1344313          DOI: 10.1097/00000658-197607000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  11 in total

1.  LIFE-SPAN IN UNTREATED BILIARY ATRESIA.

Authors:  D M HAYS; W H SNYDER
Journal:  Surgery       Date:  1963-08       Impact factor: 3.982

2.  Determination of serum lipoprotein-X for the early differentiation between neonatal hepatitis and biliary atresia.

Authors:  D P Campbell; J R Poley; P Alaupovic
Journal:  J Surg Res       Date:  1975-04       Impact factor: 2.192

3.  Hepatic portoenterostomy. Indicated or not in the treatment of biliary atresia?

Authors:  D P Campbell
Journal:  Am J Dis Child       Date:  1975-12

4.  Hepatic portoenterostomy: an assessment of its value in the treatment of biliary atresia.

Authors:  D P Campbell; E I Smith; M Bhatia; J R Poley; G R Williams
Journal:  Ann Surg       Date:  1975-05       Impact factor: 12.969

5.  Treatment of biliary atresia with special reference to hepatic porto-enterostomy and its modifications.

Authors:  M Kasai
Journal:  Prog Pediatr Surg       Date:  1974

6.  A method for the quantitative determination of the abnormal lipoprotein (LP X) of obstructive jaundice.

Authors:  H N Magnani; P Alaupović
Journal:  Clin Chim Acta       Date:  1972-05       Impact factor: 3.786

7.  The differential diagnosis of neonatal hepatitis and biliary atresia.

Authors:  D P Campbell; J R Poley; P Alaupovic; E I Smith
Journal:  J Pediatr Surg       Date:  1974-10       Impact factor: 2.545

8.  Hepatic portoenterostomy--is it indicated in the treatment of biliary atresia?

Authors:  D P Campbell; J R Poley; M Bhatia; E I Smith
Journal:  J Pediatr Surg       Date:  1974-06       Impact factor: 2.545

9.  Lipoprotein-X and the double 131 I-rose bengal test in the diagnosis of prolonged infantile jaundice.

Authors:  J R Poley; E I Smith; D J Boon; M Bhatia; C W Smith; J B Thompson
Journal:  J Pediatr Surg       Date:  1972-12       Impact factor: 2.545

10.  Hepatic portoenterostomy (the Kasai operation) for biliary atresia.

Authors:  J R Lilly; R P Altman
Journal:  Surgery       Date:  1975-07       Impact factor: 3.982

View more
  1 in total

1.  Neonatal jaundice: the surgical viewpoint.

Authors:  S Kling
Journal:  Can Med Assoc J       Date:  1980-12-20       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.